History of traumatic brain injury tied to greater chance of malignant brain tumors

New research led by investigators at Mass General Brigham suggests a link between a history of traumatic brain injury (TBI) and risk of developing a malignant brain tumor. By evaluating data from 2000-2024 of more than 75,000 people with a history of mild, moderate or severe TBI, the team found the risk of developing a malignant brain tumor was significantly higher compared to people without a history of TBI. The results were published in JAMA Network Open.

I see these results as alarming. Our work over the past five years has shown that TBI is a chronic condition with lasting effects. Now, evidence of a potential increased risk of malignant brain tumors adds urgency to shift the focus from short-term recovery to lifelong vigilance.

Alongside our earlier findings linking TBI and cardiovascular disease, this underscores the importance of long-term monitoring for anyone with a history of TBI."

Saef Izzy, MD, FNCS, FAAN, co-senior author, corresponding author, neurologist and head of the Immunology of CNS Injury Program at Brigham and Women's Hospital

The team divided the severity of TBI between mild, moderate and severe, with participants suffering from incidents ranging from car accidents to falls. In the two categories of moderate and severe, 0.6% of people (87 out of 14,944) developed brain tumors within 3-to-5 years after the TBI, which was a higher percentage than controls. Mild cases of TBI, such as those caused by concussions, were not associated with an increased risk of tumor. The aim of the study was not to establish a cause-and-effect link between moderate-to-severe TBI and malignant tumors, but rather to explore whether an association exists. Determining causality and understanding the underlying mechanisms will require a dedicated translational study in the future.

The team collaborated with researchers from Northwestern University in Chicago, the University of California, San Francisco, the University of Texas Health Science Center, and the University of Missouri. A previous study showed veterans of the Iraq and Afghanistan wars who suffered TBI experienced an increased risk of brain tumors, but previous studies on civilian populations showed conflicting results. The researchers used an international disease classifying system known as ICD codes to exclude anyone in the study with a history of brain tumor, benign tumors, and risk factors such as radiation exposure.

Previous neurotrauma studies from Mass General Brigham have looked at patients with a history of TBI and found an association with the emergence of anxiety, depression, and other psychiatric, neurological, and cardiovascular diseases, but the current study focuses on malignant tumor development.

Future imaging studies could draw a connection between the location of the TBI and where tumors developed in the brains of participants. The team would like to further study patients with repeated injuries, such as falls. 

"While there is an increased risk of tumor from TBI, the overall risk remains low. Still, brain tumor is a devasting disease and often gets detected in later stages," said lead author Sandro Marini, MD, a neurologist at Mass General Brigham. "Now, we've opened the door to monitor TBI patients more closely."

Source:
Journal reference:

Marini, S., et al. (2025). Traumatic Brain Injury and Risk of Malignant Brain Tumors in Civilian Populations. JAMA Network Open. doi.org/10.1001/jamanetworkopen.2025.28850.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ChronODE method offers precision in timing gene therapy treatments